Agroz Inc.

AGRZ
About the company

Agroz Inc., an investment holding company, operates as a vertically integrated agricultural technology company in Malaysia. The company focuses on designing, developing, building, operating, and managing large, commercial scale, and industrial grade indoor CEA vertical farms, including green butterhead, red butterhead, green coral, red coral, green oak, wild rocket, green kale, arugula, and others. The company was founded in 2020 and is based in Petaling Jaya, Malaysia.

Country: Cayman IslandsPrice: $1.87Market Cap: $3.5M

Investment snapshot

24%positive consensus
Scored 1d ago

Positive

3

BUY / PASS

Neutral / negative

4 / 9

NEUTRAL / FAIL

Median fair value

$0.39

-79.2% vs price

Models with upside

0 / 17

Positive margin of safety

Strongest signal

10 of 12 pass — Dreman and Schloss object

Key risk

No clean pass — all 8 investors flag at least one growth criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILPASSNEUTRALBUY · Rank #37 (Top 1.2%)FAILFAILPASSFAILNEUTRALFAILPASSFAILFAILNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/A
Margin of Safety-406.5%-240.7%N/A-368.5%N/A-380.5%-485.6%-146.6%-15.7%-380.5%-467.9%-546.2%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Market data at 2026-11-01

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Market data at 2026-11-01

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-10-01–2026-11-01

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-10-01–2026-11-01

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-10-01–2026-11-01

Latest source filing: 2025-05-22

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage83% pass✓ 13✗ 2▾

    10 of 12 pass — Dreman and Schloss object

    LT Debt vs Net Current AssetsLT Debt $0.0M vs NCA $1.9M
    ✓GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.00, IC: 12.7x
    ✓BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0
    ✓Lynch< 0.33
    Cash - Long-term Debt$0.1M
    ✓LynchPositive preferred
    LT Debt / Total Assets Change0.23% -> 0.08%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.29
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=12.7x, D/EBITDA=0.0x
    ✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0039; #471/4210 (top 11.2%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Growth0% pass✓ 3✗ 10▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)P/E 46.5x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$-0.00 (2022) -> $0.04 (2024)
    ✓DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency2/3 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth320.2%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency1/2 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 9.6% -> 36.3%, operating margin -6.9% -> 19.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Valuation models0% pass✗ 10▾

    AGRZ overvalued: all 10 models price fair value below $1.87 (median $0.39)

    Graham fair value$0.37
    ✗Graham-406.5% margin vs $1.87
    Buffett fair value$0.55
    ✗Buffett-240.7% margin vs $1.87
    Greenblatt fair value$0.40
    ✗Greenblatt-368.5% margin vs $1.87
    Dreman fair value$0.39
    ✗Dreman-380.5% margin vs $1.87
    Munger fair value$0.32
    ✗Munger-485.6% margin vs $1.87
    Pabrai fair value$0.76
    ✗Pabrai-146.6% margin vs $1.87
    Akre fair value$1.62
    ✗Akre-15.7% margin vs $1.87
    Marks fair value$0.39
    ✗Marks-380.5% margin vs $1.87
    Ackman fair value$0.33
    ✗Ackman-467.9% margin vs $1.87
    Templeton fair value$0.29
    ✗Templeton-546.2% margin vs $1.87
  • Valuation15% pass✓ 6✗ 22▾

    11 of 13 flag AGRZ's valuation — Graham, Lynch, Dreman +8 more

    Price / 3-yr avg EPS71.5x
    ✗Graham<= 15x
    Price-to-Book Ratio12.4x
    ✗Graham<= 1.5x
    P/E x P/B889.20
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)P/E 46.5x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value53.2%
    ✓Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=53.2%, ROC=95.9%
    ✓GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS46.5x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)181.5x
    ✗Dreman< 8x
    Price / Book Value per Share12.4x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=46.5x, OE Yield=2.5%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=46.5x, FCF Yield=5.5%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=46.5x, P/B=12.4x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-376.7% (IV=$0.39 vs Price=$1.87)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share202.4x
    ✗Ackman<= 25
    Price vs. Trailing Low986% of trailing low ($0.19)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+22.79%; #240/6340 (top 3.8%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.8912; #1698/6449 (top 26.3%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS46.5x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share12.44x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+2.6512; #891/5247 (top 17.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+5.47%; #1488/4519 (top 32.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+358.19%; #99/6202 (top 1.6%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Profitability25% pass✓ 13✗ 22▾

    12 of 16 flag AGRZ's profitability — Graham, Buffett, Lynch +9 more

    Positive EPS (10 years)2/4 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)2/4 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-27.4%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$0.9M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)P/E 46.5x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE25.6%
    ✓Lynch> 15%
    EBIT / Enterprise Value53.2%
    ✓Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=53.2%, ROC=95.9%
    ✓GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets6.88%
    ✓PiotroskiROA > 0
    ROA Change YoY16.61% -> 6.88% (delta: -9.73%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=1.84%, ROA=6.88%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY44.7% -> 36.3%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue15.5%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity25.6%
    ✓Dreman> 12%
    Margin of SafetyP/E=46.5x, P/B=12.4x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-27.4% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-376.7% (IV=$0.39 vs Price=$1.87)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency2/3 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue19.6%
    ✓Ackman>= 15%
    Net Income / Shareholders Equity25.6%
    ✓Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-6.9% (2022) -> 19.6% (2024)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 9.6% -> 36.3%, operating margin -6.9% -> 19.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+22.79%; #240/6340 (top 3.8%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+29.02%; #1487/3702 (top 40.2%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+25.57%; #570/5226 (top 10.9%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Cash Flow30% pass✓ 4✗ 8▾

    7 of 10 flag AGRZ's cash flow — Piotroski, Dreman, Pabrai +4 more

    Free Cash Flow Proxy$0.9M
    ✓BuffettPositive and growing
    FCF Positive and Growing$0.2M
    ✓LynchPositive and growing
    Operating Cash Flow$0.2M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=1.84%, ROA=6.88%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)181.5x
    ✗Dreman< 8x
    P/E or FCF YieldP/E=46.5x, FCF Yield=5.5%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive1/3 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap0.5%
    ✗Ackman>= 4%
    Price / FCF per Share202.4x
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency1/3 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$0.2M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+5.47%; #1488/4519 (top 32.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts31% pass✓ 4✗ 9▾

    Split decision: 9 FAIL · 4 NEUTRAL · 3 PASS

    Overall verdict
    ✗GrahamFAIL (1/9)✓BuffettPASS (4/9)•LynchNEUTRAL (5/7)✓GreenblattRank #37✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (4/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)•AkreNEUTRAL (4/6)✗MarksFAIL (1/5)✓AckmanPASS (4/9)✗TempletonFAIL (3/8)✗SleepFAIL (2/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency50% pass✓ 6✗ 5▾

    4 of 8 pass — Graham, Piotroski, Dreman +1 more object

    Current Ratio1.29
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)82.3%
    ✓Buffett> 10%
    ROIC - WACC+72.3%
    ✓BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)95.9%
    ✓Greenblatt> 25%
    Current Ratio Change YoY2.63 -> 1.29
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.82x -> 0.80x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.29
    ✗Dreman> 1.5
    Return on Invested Capital45.9%
    ✓Munger> 15%
    ROIC (high and growing)FY2022: ROIC=unavailable; FY2023: ROIC=91.9%; FY2024: ROIC=45.9%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC45.9% (RR=100% x ROIC=45.9%)
    ✓AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)2/2 years above 12% (latest 45.9%)
    ✓SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.

Company Profile

Industry: Agriculture
SIC Sector: Agricultural Crops
Size: Micro Cap($3.5M)
Revenue: $9.2M+132.3% YoY
Net Income: $787040.45-1.8% YoY

Financial Snapshot

Operating Margin19.6%
Return on Equity25.6%
Debt / Equity0.00
Current Ratio1.29
EPS (Diluted)$0.04−0.5% 1y
Shares Retired−2.1% / −2.1% 2y

Similar Companies

CTVACorteva, Inc.
$6.3B
CALMCAL-MAINE FOODS INC
$3.1B
DOLEDole plc
$1.3B
AGROAdecoagro S.A.
$1.3B

Shareholder Return

Fiscal 2024

Issued 2.1% of shares last year, 2.1% issued over two.

Buybacks
—
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY24
−0.5% = −1.8% + 1.3%
Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

MetricFY 2024
Sources
  • 20-F · 2025-05-22
FY 2023
Sources
  • 20-F · 2025-05-22
FY 2022
Sources
  • 20-F · 2025-05-22
FY 2021
Sources
  • 20-F · 2025-05-22
Market Cap$3.5Mcurrent------
Revenue$9.2M↑132%$3.9M↑508%$648.1K--
Operating Income$1.8M↑33%$1.3M↑3097%-$45.0K--
Net Income$787.0K↓2%$801.2K↑1322%-$65.6K--
EPS (Diluted)$0.04↓1%$0.04↑1892%$-0.00--
Gross Margin36.3%↓19%44.7%↑367%9.6%—
Operating Margin19.6%↓43%34.2%↑593%-6.9%—
ROE25.6%↓63%70.0%↑139%-177.6%—
Total Debt$11.9K↓17%$14.3K----
Shareholders' Equity$3.1M↑169%$1.1M↑3001%$36.9K↑127%-$138.3K
Current Ratio1.29↓51%2.63——
Debt / Equity0.00↓69%0.01——
Operating Cash Flow$210.9K↑129%-$727.5K↓16%-$627.3K--
Free Cash Flow$189.1K↑124%-$773.9K↓22%-$634.0K--

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Agriculture

AGRZ vs Peers — Financial Grading

Revenue$9.2MBottom 25%
Net Income$787040.45Bottom 25%
ROE25.6%Top 25%
D/E0.00Top 25%
Op. Margin19.6%Top 25%
Curr. Ratio1.29Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Corteva, Inc.CTVA$6.3B$9.43$17.4B$1.1B4.5%0.11—1.435/92/94/73/3F-Score 79/11
CAL-MAINE FOODS INCCALM$3.1B$66.45$2.9B$316.7M12.0%—12.0%7.706/93/92/71/3F-Score 66/11
Dole plcDOLE$1.3B$14.32$9.2B$51.3M3.8%0.632.4%1.174/91/90/71/3F-Score 63/11
Adecoagro S.A.AGRO$1.3B$9.11$1.5B$92.3M6.7%0.5712.0%2.545/92/93/70/3F-Score 76/11
DEL MONTE CORPDMC$1.3B$27.22$4.3B$90.7M4.5%0.093.2%2.165/91/92/70/3F-Score 86/11
Mission Produce, Inc.AVO$1.0B$11.83$1.4B$37.7M6.4%0.164.7%1.952/90/91/70/3F-Score 83/11
CALAVO GROWERS INCCVGW$490.7M$27.63$648.4M$19.8M9.6%0.023.0%2.473/92/91/71/3F-Score 72/11
BrasilAgro - Brazilian Agricultural Real Estate CoLND$311.8M$3.13$160.2M$25.2M6.3%—23.5%—5/93/90/71/3F-Score 54/11